Exploration of the Protection of Riboflavin Laurate on Oral Mucositis Induced by Chemotherapy or Radiotherapy at the Cellular Level: What Is the Leading Contributor?

Dexuan Yang; Qishou Xu; Shanshan Wang; Shoujun Yuan; Yinghong An; Zixue Xuan

首页> 外文期刊>International Journal of Molecular Sciences >Exploration of the Protection of Riboflavin Laurate on Oral Mucositis Induced by Chemotherapy or Radiotherapy at the Cellular Level: What Is the Leading Contributor?

【24h】

Exploration of the Protection of Riboflavin Laurate on Oral Mucositis Induced by Chemotherapy or Radiotherapy at the Cellular Level: What Is the Leading Contributor?

机译：在细胞水平上探讨月桂酸核黄素对化学疗法或放射疗法诱导的口腔粘膜炎的保护作用：主要作用是什么？

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Oral or gastrointestinal mucositis is a frequent phenomenon in cancer patients receiving chemotherapy or radiotherapy. In addition, several clinical investigations have demonstrated in recent years that riboflavin laurate has the potential to protect the patients from the disease induced by chemotherapy or radiotherapy. In our studies, it is observed that riboflavin laurate can ameliorate either chemotherapy- or radiotherapy-induced toxicities on Helf cells, and the effect is greater than that of riboflavin. In addition, riboflavin laurate is able to transport through the Caco-2 cell monolayer as the prototype, indicating the protective effects may be produced by the prototype of riboflavin laurate, rather than simply by the released riboflavin.

机译：在接受化学疗法或放射疗法的癌症患者中，口腔或胃肠道粘膜炎是常见现象。另外，近年来的一些临床研究表明，月桂核黄素具有保护患者免受化学疗法或放射疗法诱发的疾病的潜力。在我们的研究中，观察到月桂酸核黄素可以改善化疗或放疗诱导的对Helf细胞的毒性，其作用要大于核黄素。此外，月桂核黄素能够作为原型通过Caco-2细胞单层运输，这表明保护作用可能是由月桂核黄素的原型产生的，而不是简单地由释放的核黄素产生的。

著录项

来源
《International Journal of Molecular Sciences》 |2013年第3期|共12页
作者
Dexuan Yang; Qishou Xu; Shanshan Wang; Shoujun Yuan; Yinghong An; Zixue Xuan;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类生物物理学;
关键词

相似文献

外文文献
中文文献
专利

1. Efficacy of low-level laser therapy and aluminum hydroxide in patients with chemotherapy and radiotherapy-induced oral mucositis [J] . Aline Gouvêa De Lima, Igor Moysés Longo Snitcosky, Maria Paula Siqueira De Melo Peres, Brazilian Dental Journal . 2010,第3期

机译：低水平激光疗法和氢氧化铝在化学疗法和放射疗法诱发的口腔粘膜炎患者中的疗效
2. Low-level laser for prevention and therapy of oral mucositis induced by chemotherapy or radiotherapy. [J] . Klastersky J Current Opinion in Oncology . 2005,第3期

机译：低水平激光用于预防和治疗化学疗法或放射疗法引起的口腔粘膜炎。
3. Low level helium neon laser therapy for chemoradiotherapy induced oral mucositis in oral cancer patients - A randomized controlled trial [J] . GautamA.P., FernandesD.J., VidyasagarM.S., Oral oncology . 2012,第9期

机译：低水平氦氖激光治疗口腔癌患者放化疗引起的口腔粘膜炎-一项随机对照试验
4. Use of Laser Photomodulation in the Evolution of Oral Mucositis Associated to Cyclophosphamide, Methotrexate, 5-Fluouracil - CMF in 5 Fluouracil + Adriamycin + Cyclophosphamide - FAC Chemotherapy Protocols in Patients with Breast Cancer [C] . Maria de Fatima Lima Ferreira, Fabiola Bastos de Carvalho, Susana C. P. S. de Oliveira, Mechanisms for low-light therapy VIII . 2013

机译：激光光调节在5种氟尿嘧啶+阿霉素+环磷酰胺-FAC化疗方案中与环磷酰胺，甲氨蝶呤，5-氟尿嘧啶-CMF相关的口腔黏膜演变中的应用
5. Oral care intervention to alleviate chemotherapy-induced oral mucositis in children with cancer. [D] . Cheng, Kin Fong. 2002

机译：口腔护理干预措施可减轻癌症儿童化疗引起的口腔粘膜炎。
6. Exploration of the Protection of Riboflavin Laurate on Oral Mucositis Induced by Chemotherapy or Radiotherapy at the Cellular Level: What Is the Leading Contributor? [O] . Zixue Xuan, Yinghong An, Dexuan Yang, 2013

机译：在细胞水平上探讨月桂酸核黄素对化学疗法或放射疗法诱导的口腔粘膜炎的保护作用：主要作用是什么？
7. Exploration of the Protection of Riboflavin Laurate on Oral Mucositis Induced by Chemotherapy or Radiotherapy at the Cellular Level: What Is the Leading Contributor? [O] . Shanshan Wang, Qishou Xu, Dexuan Yang, 2013

机译：在核心水平上化学疗法或放射疗法诱导口服粘膜炎对核黄素的保护作用的探索：主要贡献者是什么？

Exploration of the Protection of Riboflavin Laurate on Oral Mucositis Induced by Chemotherapy or Radiotherapy at the Cellular Level: What Is the Leading Contributor?

摘要

著录项

相似文献

相关主题

期刊订阅